Bulletin
Investor Alert

New York Markets Close in:

Denali Therapeutics Inc.

NAS: DNLI

GO
/marketstate/country/us

Market open

 --Real time quotes

Mar 21, 2023, 2:02 p.m.

/zigman2/quotes/200043077/composite

$

23.06

Change

-0.28 -1.18%

Volume

Volume 303,960

Real time quotes

/zigman2/quotes/200043077/composite

Previous close

$ 23.33

$ 23.06

Change

-0.28 -1.18%

Day low

Day high

$23.05

$23.66

Open

52 week low

52 week high

$20.24

$39.43

Open
Sorry, there are no transactions available for this individual.

Officers and Executives

Dr. Ryan J. Watts
President, Chief Executive Officer & Director
Dr. Alexander O. Schuth
Secretary, Chief Operating & Financial Officer
Dr. Joe Lewcock
Chief Scientific Officer
Dr. Carole Ho
Chief Medical Officer & Head-Development
Dr. Dana Andersen
CTO & Chief Manufacturing Officer
Ms. Katie Peng
Chief Commercial Officer
Mr. Steve E. Krognes
Director
Dr. Laura G. Hansen
Vice President-Investor Relations
Ms. Cindy Dunkle
Chief People Officer
Dr. Chris Walsh
Associate General Counsel
Ms. Erica Kratz
Vice President-Regulatory
Dr. Vicki L. Sato
Non-Executive Chairman
Ms. Nancy A. Thornberry
Independent Director
Mr. Erik C. Harris
Independent Director
Dr. Marc Tessier-Lavigne
Independent Director
Dr. Douglas G. Cole
Independent Director
Mr. Jay T. Flatley
Independent Director
Dr. David Paul Schenkein
Independent Director
Mr. Peter S. Klein
Independent Director
Ms. Jennifer E. Cook
Independent Director
Link to MarketWatch's Slice.